|
|
Other links at Articles > Dermatology |
| 1. |
FDA Safety Changes: Metvixia, Clozaril, Velcade
|
|
|
The FDA has approved revisions to the safety labeling for methyl aminolevulinate HCl 16.8% cream (Metvixia), clozapine tablets (Clozaril), and bortezomib intravenous injection (Velcade). Medscape Medical News
|
| 3. |
Aesthetic Medicine
|
|
|
In this issue: Filler safety, laser treatment for axillary hyperhidrosis, and dual wavelength laser treatment for telangiectasias.
Medscape Dermatology
|
|
|